AZD5672 Bioavailability Study in Healthy Male and Female Subjects

Exclusion Criteria

• - History of clinically significant cardio- or cerebrovascular, pulmonary, renal, hepatic, neurological, mental or gastrointestinal disorder or any other major disorder that may interfere with the objectives of the study, as judged by the Investigator
• - Clinically significant illness as judged by the Investigator, within two weeks before the first administration of investigational product.
• - Female subjects who have a positive pregnancy test or who are pregnant or breast-feeding